Загрузка...
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic lung disease which has seen new opportunity for drug treatment in the last several years with the approval of nintedanib and pirfenidone, two antifibrotic agents aimed at slowing decline in lung function as defined by FVC on pulmonary...
Сохранить в:
| Опубликовано в: : | Ther Clin Risk Manag |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322512/ https://ncbi.nlm.nih.gov/pubmed/30655671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S160248 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|